SerenoCem™ granules in mastoid obliteration surgery: A 2-year follow-up case series of 55 patients to determine the risk of progressive bone resorption

Clin Otolaryngol. 2019 Nov;44(6):1153-1155. doi: 10.1111/coa.13422. Epub 2019 Sep 11.

Authors

Matthew Cherko¹, Laura Harrison¹, Gaurav Chawdhary¹, Matthew Bull², Ian Bottrill³, Christopher Aldren¹

Affiliations

¹ Department of Otorhinolaryngology, Wexham Park Hospital, Slough, UK.
² Department of Radiology, Wexham Park Hospital, Slough, UK.
³ Department of Otorhinolaryngology, John Radcliffe Hospital, Oxford, UK.

PMID: 31446670
DOI: 10.1111/coa.13422

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Bone Resorption*
Disease Progression
Follow-Up Studies
Glass Ionomer Cements / therapeutic use*
Humans
Mastoid / diagnostic imaging*
Mastoid / surgery*
Reoperation
Risk Factors
Tomography, X-Ray Computed*

Substances

Glass Ionomer Cements
SerenoCem